CHARACTERISTICS OF YOUNG ILLICIT DRUG INJECTORS WHO USE NORTH AMERICA'S FIRST MEDICALLY SUPERVISED SAFER INJECTING FACILITY
Gardado en:
| Autor Principal: | |
|---|---|
| Outros autores: | |
| Formato: | Libro |
| Idioma: | Lingua castelá inglés |
| Subjects: | |
| Acceso en liña: | Path |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares: CHARACTERISTICS OF YOUNG ILLICIT DRUG INJECTORS WHO USE NORTH AMERICA'S FIRST MEDICALLY SUPERVISED SAFER INJECTING FACILITY
- Injection drug use cessation and use of North America's first medically supervised safer injecting facility
- Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study
- IDU perspectives on the design and operation of North America's first medically supervised injection facility
- SAFER INJECTION FACILITIES IN NORTH AMERICA: THEIR PLACE IN PUBLIC POLICY AND HEALTH INITIATIVES
- ATTENDANCE, DRUG USE PATTERNS, AND REFERRALS MADE FROM NORTH AMERICA'S FIRST SUPERVISED INJECTION FACILITY
- THE CANADIAN GOVERNMENT'S TREATMENT OF SCIENTIFIC PROCESS AND EVIDENCE: INSIDE THE EVALUATION OF NORTH AMERICA'S FIRST SUPERVISED INJECTING FACILITY